氨甲环酸与全髋及全膝关节置换术后假体周围关节感染风险降低的关联:一项纳入超过200万患者的系统综述与Meta分析
该系统综述与Meta分析纳入6项研究、共2,098,469例关节置换术,评估初次全髋关节置换术(THA)和初次全膝关节置换术(TKA)中使用氨甲环酸(TXA)与术后假体周围关节感染(PJI)风险的关联。结果显示TXA使用与PJI风险降低相关(OR=0.63,95%CI 0.42-0.96,P<.001),PJI发生率降低0.4%(RD=-0.0038,95%CI -0.005至-0.002,P<.001)。随访超过90天的亚组中,TXA与PJI风险降低相关(OR=0.43,95%CI 0.35-0.53,P<.001),PJI发生率降低1%(RD=-0.0095,95%CI -0.013至-0.005,P<.001)。
要点
- TXA使用与初次THA和TKA术后PJI风险降低相关(OR=0.63,95%CI 0.42-0.96,P<.001)。
- TXA使用与PJI发生率降低0.4%相关(RD=-0.0038,95%CI -0.005至-0.002,P<.001)。
- 随访超过90天的亚组中TXA与PJI风险降低相关(OR=0.43,95%CI 0.35-0.53,P<.001)。
核心结论
- 该Meta分析表明TXA使用与PJI风险降低相关,RD分析显示TXA使用约降低PJI发生率0.4%。
- 这些发现为初次THA和初次TKA中常规使用TXA提供了更多数据支持。
研究设计与样本
- 系统综述与Meta分析,检索自建库至2022年10月17日,最终纳入6项研究。
- 共纳入2,098,469例关节置换术,评估TXA使用与PJI风险的关联。
- 采用比值比(OR)及95%置信区间(CI)和风险差(RD)进行分析。
- 亚组分析比较随访90天以内与超过90天的研究。
主要发现
- 在2,098,469例关节置换术中,TXA使用与总体PJI风险降低相关(OR=0.63,95%CI 0.42-0.96,P<.001)。
- TXA使用与PJI发生率降低0.4%相关(RD=-0.0038,95%CI -0.005至-0.002,P<.001)。
- 随访超过90天的患者中,TXA与PJI风险降低相关(OR=0.43,95%CI 0.35-0.53,P<.001)。
- 随访超过90天的患者中,TXA与PJI发生率降低1%相关(RD=-0.0095,95%CI -0.013至-0.005,P<.001)。
关键数值与推荐
- TXA使用与总体PJI风险降低相关:OR=0.63(95%CI 0.42-0.96),P<.001。
- TXA使用与PJI发生率降低0.4%相关:RD=-0.0038(95%CI -0.005至-0.002),P<.001。
- 随访超过90天亚组中TXA与PJI风险降低相关:OR=0.43(95%CI 0.35-0.53),P<.001。
- 随访超过90天亚组中TXA与PJI发生率降低1%相关:RD=-0.0095(95%CI -0.013至-0.005),P<.001。
临床怎么用
- 作者指出这些发现为初次THA和初次TKA中常规使用TXA提供了更多数据支持。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to perform a systematic review and meta-analysis to evaluate the association between tranexamic acid (TXA) use during primary total hip arthroplasty (THA) and primary total knee arthroplasty (TKA), and the risk of developing periprosthetic joint infection (PJI) after these procedures. METHODS: A systematic review was carried out from inception to October 17, 2022. There were 6 studies that were ultimately included in the meta-analysis. The association between the development of PJI and TXA was analyzed using odds ratios (ORs) with 95% confidence intervals (CIs) and estimates of risk difference (RD). Subgroup analysis was performed to evaluate only studies reporting out to 90 days of follow-up versus more than 90 days of follow-up. RESULTS: Among 2,098,469 arthroplasties, TXA utilization was associated with an overall lower risk of PJI (OR = 0.63 [95% CI 0.42 to 0.96], P < .001) and a 0.4% lower incidence of PJI (RD = -0.0038, 95% CI [-0.005 to -0.002], P < .001). When subgrouping the studies according to length of follow-up, TXA was associated with a lower risk of PJI (OR = 0.43 [95% CI 0.35 to 0.53], P < .001) and a 1% lower incidence of PJI (RD = -0.0095 [95% CI -0.013 to -0.005], P < .001) in patients followed for more than 90 days. CONCLUSIONS: This meta-analysis demonstrates that TXA use is associated with a reduced risk of PJI, with our RD analysis identifying an approximately 0.4% reduction in PJI rates with TXA use. These findings provide even more data to support the routine use of TXA during primary THA and primary TKA.
引用
- Elmenawi KA, Mohamed FAE, Poilvache H, et al. Association Between Tranexamic Acid and Decreased Periprosthetic Joint Infection Risk in Patients Undergoing Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of Over 2 Million Patients. J Arthroplasty. 2024. PMID: 38636676. doi:10.1016/j.arth.2024.04.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。